Barry Meisenberg, MD

Medical Director, Geaton and JoAnn DeCesaris Cancer Institute

Chair of Quality Improvement and Health Systems Research

Dr. Meisenberg is medical director of the AAMC Geaton and JoAnn DeCesaris Cancer Institute, a role he has held since 2008. He has provided visionary leadership for the multi-disciplinary programs of the institute and emerging technologies to offer patients the best in cancer treatment and care. Under his leadership, the Institute has expanded to include implementation of Novalis Tx™ radiosurgery, the Cancer Survivorship Program with augmented cancer rehabilitation program, , the expansion of the Outpatient Infusion Center, expansion of the AAMC Breast Center, and the creation of the Rapid Access Lung Program.

Dr. Meisenberg is also Chair of Quality Improvement and Health Systems Research for AAHS. In this role he leads Center for Health Care Improvement with an overall goal to study, define and implement care and process innovation. He heads the Anne Arundel Health System Research Institute.

A nationally recognized oncologist and hematology expert, Dr. Meisenberg came to AAMC from the University of Maryland School of Medicine, where he headed the Division of Hematology/Oncology at the Marlene and Stewart Greenebaum Cancer Center and was Deputy Director for Clinical Affairs of the Cancer Center. Previously, he held clinical and academic positions at Duke University. He also is a visiting professor of oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Dr. Meisenberg joined the JHCRN in 2008 to facilitate cancer research and had expanded his role within the JHCRN to become one of the primary leaders in the JHCRN